Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology Evotec ...

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

Evotec announced in May of 2022 that the Company has further extended and expanded its partnership with Bristol Myers Squibb for another 8 years as the initial collaboration proved to be highly ...

Evotec (EVO) announced progress within the company’s strategic partnership with Bristol Myers Squibb (BMY) relating to building a molecular glue-based pipeline. Key scientific achievements drive the ...

Sept 26 (Reuters) - German drug and development company Evotec (EVTG.DE), opens new tab has entered into a technology development partnership with Novo Nordisk (NOVOb.CO), opens new tab to support ...

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy.

On Monday, Evotec stock experienced a shift in market sentiment as Jefferies adjusted its stance on the biotechnology company's stock. Previously rated as a Buy, Evotec (NASDAQ:EVO) has now been ...

On Monday, Evotec AG (EVT:GR) (NASDAQ:EVO) experienced a change in stock rating as Jefferies shifted its perspective from Buy to Hold. The firm also adjusted the price target for Evotec's shares ...

On Monday, Evotec AG (EVT:GR) (NASDAQ:EVO) experienced a change in stock rating as Jefferies shifted its perspective from Buy to Hold. The firm also adjusted the price target for Evotec's shares to €6 ...

On Monday, Evotec stock experienced a shift in market sentiment as Jefferies adjusted its stance on the biotechnology company's stock. Previously rated as a Buy, Evotec (NASDAQ:EVO) has now been ...